Compare Stocks: AMGN, KO, and DOW

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMGN Amgen	$466.01 +1.1%	$419.96	$288.00 ▼ $475.65	$251.94B	0.41	2.63 million shs	3.29 million shs
DOW DOW	$34.66 +3.1%	$29.89	$20.93 ▼ $42.74	$25.12B	0.43	8.46 million shs	11.05 million shs
KO Coca-Cola	$94.11 +1.4%	$89.47	$67.27 ▼ $95.37	$404.72B	0.32	16.76 million shs	18.36 million shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMGN Amgen	0.00%	+6.09%	+14.42%	+20.99%	+59.72%
DOW DOW	0.00%	+6.37%	+25.81%	+14.28%	+39.25%
KO Coca-Cola	0.00%	+1.44%	+9.39%	+7.35%	+37.78%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMGN Amgen	$466.01 +1.1%	$419.96	$288.00 ▼ $475.65	$251.94B	0.41	2.63 million shs	3.29 million shs
DOW DOW	$34.66 +3.1%	$29.89	$20.93 ▼ $42.74	$25.12B	0.43	8.46 million shs	11.05 million shs
KO Coca-Cola	$94.11 +1.4%	$89.47	$67.27 ▼ $95.37	$404.72B	0.32	16.76 million shs	18.36 million shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMGN Amgen	0.00%	+6.09%	+14.42%	+20.99%	+59.72%
DOW DOW	0.00%	+6.37%	+25.81%	+14.28%	+39.25%
KO Coca-Cola	0.00%	+1.44%	+9.39%	+7.35%	+37.78%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMGN Amgen	2.30	Hold	$389.71	-16.37% Downside
DOW DOW	2.33	Hold	$35.44	2.26% Upside
KO Coca-Cola	2.92	Moderate Buy	$97.26	3.35% Upside

Current Analyst Ratings Breakdown

Latest AMGN, KO, and DOW Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/28/2026	KO Coca-Cola	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$104.00 ➝ $106.00
10/28/2026	KO Coca-Cola	Morgan Stanley Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Overweight	$100.00 ➝ $103.00
10/28/2026	KO Coca-Cola	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Overweight	$90.00 ➝ $100.00
10/28/2026	KO Coca-Cola	Freedom Broker Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Hold	$85.00 ➝ $89.00
10/28/2026	KO Coca-Cola	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$102.00 ➝ $103.00
10/28/2026	KO Coca-Cola	JPMorgan Chase & Co. Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Overweight	$95.00 ➝ $98.00
10/28/2026	KO Coca-Cola	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$100.00 ➝ $104.00
10/26/2026	KO Coca-Cola	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Outperform	$96.00
10/26/2026	KO Coca-Cola	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Overweight	$95.00 ➝ $102.00
10/23/2026	KO Coca-Cola	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Buy (A+) ➝ Buy (A)
10/23/2026	DOW DOW	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Neutral	$30.00 ➝ $33.00

(Data available from 11/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMGN Amgen	$36.75B	6.86	$33.82 per share	13.78	$16.08 per share	28.98
DOW DOW	$39.97B	0.63	$3.03 per share	11.44	$24.36 per share	1.42
KO Coca-Cola	$47.94B	8.44	$3.26 per share	28.87	$9.19 per share	10.24

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMGN Amgen	$7.71B	$16.09	28.96	18.94	3.41	22.95%	124.14%	13.18%	11/3/2026 (Estimated)
DOW DOW	-$2.62B	-$1.28	N/A	20.75	0.46	-2.11%	7.10%	2.04%	N/A
KO Coca-Cola	$13.11B	$3.40	27.68	26.66	3.67	28.65%	38.79%	13.50%	N/A

Latest AMGN, KO, and DOW Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/3/2026	Q3 2026	AMGN Amgen	$5.79	N/A	N/A	N/A	$10.07 billion	N/A
10/27/2026	Q3 2026	KO Coca-Cola	$0.8810	$0.91	+$0.0290	$0.93	$12.92 billion	$13.35 billion
10/22/2026	Q3 2026	DOW DOW	$0.6380	$0.71	+$0.0720	$0.62	$11.22 billion	$11.27 billion
8/4/2026	Q2 2026	AMGN Amgen	$5.62	$6.29	+$0.67	$4.37	$9.43 billion	$10.05 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMGN Amgen	$10.08	2.16%	+8.27%	62.65%	14 Years
DOW DOW	$1.40	4.04%	-5.59%	N/A	N/A
KO Coca-Cola	$2.12	2.25%	+4.46%	62.35%	64 Years

Latest AMGN, KO, and DOW Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
10/15/2026	KO Coca-Cola	quarterly	$0.53	2.31%	12/1/2026	12/1/2026	12/15/2026
10/27/2026	AMGN Amgen	quarterly	$2.52	2.25%	11/20/2026	11/20/2026	12/11/2026
10/15/2026	DOW DOW	quarterly	$0.35	4.72%	11/30/2026	11/30/2026	12/11/2026
8/12/2026	DOW DOW	quarterly	$0.35	4.59%	8/31/2026	8/31/2026	9/11/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMGN Amgen	4.44	1.37	1.13
DOW DOW	0.95	1.76	1.14
KO Coca-Cola	0.93	1.38	1.12

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMGN Amgen	76.50%
DOW DOW	64.00%
KO Coca-Cola	70.26%

Insider Ownership

Company	Insider Ownership
AMGN Amgen	0.85%
DOW DOW	0.50%
KO Coca-Cola	0.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMGN Amgen	31,500	540.63 million	536.04 million	Optionable
DOW DOW	34,600	723.88 million	720.26 million	Optionable
KO Coca-Cola	65,900	4.30 billion	4.26 billion	Optionable

AMGN, KO, and DOW Headlines

Recent News About These Companies

Coca-Cola and Procter & Gamble Are Up This Month. Which Dow Dividend Stock Is the Better Buy Now?

October 31 at 8:20 AM | fool.com

MarketBeat Week in Review – 10/26 - 10/30 (KO)

...

October 31 at 7:00 AM | marketbeat.com

KO Q3 deep dive: broad-based volume gains and disciplined margin expansion amid cost pressures

October 31 at 3:46 AM | finance.yahoo.com

Coca-Cola (NYSE:KO) Shares Up 1.2% Following Analyst Upgrade

October 31 at 2:01 AM | americanbankingnews.com

The Open Question Under Coca-Cola Stock's Price

October 30 at 10:46 PM | trefis.comT

US Consumers Keep Spending, But They’re Watching Value: Visa and Coca-Cola Offer a Split Read on the Economy

October 30 at 10:46 PM | finance.yahoo.com

Coca-Cola Co. stock underperforms Friday when compared to competitors despite daily gains

October 30 at 5:44 PM | marketwatch.com

Coca-Cola (NYSE:KO) Stock Jumps 1.4% - Still a Buy?

October 30 at 5:21 PM | marketbeat.com

Promising Water Stocks To Research - October 30th

October 30 at 3:13 PM | marketbeat.com

Kraft Heinz vs. Coca-Cola: Stagnant Versus Growing Revenue Trends in Consumer Goods

October 30 at 12:33 PM | fool.com

No Tricks, Just Treats: 3 Dividend Stocks With Payouts You Can Trust

October 30 at 11:50 AM | 247wallst.com

No Tricks, Just Treats: 3 Dividend Stocks With Payouts You Can Trust

October 30 at 11:16 AM | 247wallst.com

4 Dividend Kings With 50-Plus Years of Payout Increases for Retirement Income

October 30 at 10:17 AM | 247wallst.com

Coca-Cola’s Q3 earnings call: our top 5 analyst questions

October 30 at 7:42 AM | finance.yahoo.com

Is Coca-Cola Stock Still Worth Owning After Its Third Quarter?

October 30 at 7:42 AM | trefis.comT

38,878 Coca-Cola Company (The) $KO Shares Bought by Soltis Investment Advisors LLC

October 30 at 6:23 AM | marketbeat.com

Coca-Cola Bottlers Japan Q3 2026 Earnings Call Transcript

October 30 at 6:11 AM | benzinga.com

Warren Buffett's Successor, Greg Abel, Has 54% of Berkshire Hathaway's $365 Billion Portfolio Invested in 4 Proven Winners

October 30 at 5:06 AM | fool.com

Coca-Cola Bottlers Japan Completes Buyback, Cancels Shares and Launches New Program

October 30 at 4:31 AM | tipranks.com

Coca-Cola Company (The) $KO Shares Acquired by Choreo LLC

October 30 at 4:23 AM | marketbeat.com

Coca-Cola Bottlers Japan Swings Back to Profit and Lifts Shareholder Returns

October 30 at 3:11 AM | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

AMGN, KO, and DOW Company Descriptions

Amgen NASDAQ:AMGN

$466.01 +5.28 (+1.15%)

Closing price 10/30/2026 04:00 PM Eastern

Extended Trading

$466.00 -0.01 (0.00%)

As of 10/30/2026 07:54 PM Eastern

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

DOW NYSE:DOW

$34.66 +1.04 (+3.09%)

Closing price 10/30/2026 03:59 PM Eastern

Extended Trading

$34.53 -0.13 (-0.36%)

As of 10/30/2026 07:57 PM Eastern

Dow, Inc. is a materials science company, which engages in the development of innovative solutions. It operates through the following segments: Packaging and Specialty Plastics, Industrial Intermediates and Infrastructure, and Performance Materials and Coatings. The Packaging and Specialty Plastics segment consists of hydrocarbons and energy and packaging and specialty plastics. The Industrial Intermediates and Infrastructure segment covers the industrial solutions and polyurethanes and construction chemicals. The Performance Materials and Coatings segment includes coatings and performance monomers and consumer solutions. The company was founded in 1897 and is headquartered in Midland, MI.

Coca-Cola NYSE:KO

$94.11 +1.29 (+1.39%)

Closing price 10/30/2026 03:59 PM Eastern

Extended Trading

$94.19 +0.08 (+0.09%)

As of 10/30/2026 07:59 PM Eastern

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AMGN, KO, and DOW Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AMGN, KO, and DOW Earnings

Compare Dividends

Latest AMGN, KO, and DOW Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AMGN, KO, and DOW Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AMGN, KO, and DOW Company Descriptions

Amgen NASDAQ:AMGN

DOW NYSE:DOW

Coca-Cola NYSE:KO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AMGN, KO, and DOW Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AMGN, KO, and DOW Earnings

Compare Dividends

Latest AMGN, KO, and DOW Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AMGN, KO, and DOW Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AMGN, KO, and DOW Company Descriptions

Amgen NASDAQ:AMGN

DOW NYSE:DOW

Coca-Cola NYSE:KO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools